Related Experiment Video
Updated: Jul 30, 2026
09:44
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 26, 2016
Inhaled corticosteroids and adrenal insufficiency
Archives of Disease in Childhood
|November 29, 2002
Summary
Inhaled corticosteroids are generally safe for respiratory conditions. However, extremely high doses, particularly of fluticasone, may pose risks.
Area of Science:
- Pulmonology and Pharmacology
Background:
- Inhaled corticosteroids (ICS) are a cornerstone therapy for managing chronic respiratory diseases like asthma and COPD.
- Standard doses of ICS are widely recognized for their favorable safety profile and efficacy.
Discussion:
- This summary highlights the safety of inhaled steroids at recommended dosages.
- It specifically cautions against the potential risks associated with supra-therapeutic or very high doses.
- Particular attention is drawn to fluticasone, a potent inhaled corticosteroid, suggesting dose-dependent adverse effects.
Key Insights:
- Inhaled steroids demonstrate a strong safety record when used at normal therapeutic levels.
- Very high doses of inhaled steroids, including fluticasone, warrant careful consideration due to potential adverse events.
- Dose optimization is crucial for maximizing therapeutic benefits while minimizing risks.
Outlook:
- Further research may elucidate specific safety thresholds and long-term implications of high-dose ICS use.
- Clinical guidelines may need to reinforce vigilance regarding dosing strategies for potent ICS like fluticasone.
- Personalized medicine approaches could tailor ICS dosing based on individual patient factors and risk profiles.
More Related Videos
Related Concept Videos
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...